Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $18.95, down -1.86% from its previous closing price of $19.31. In other words, the price has decreased by -$1.86 from its previous closing price. On the day, 5.76 million shares were traded. HIMS stock price reached its highest trading level at $19.24 during the session, while it also had its lowest trading level at $18.3.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.83. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Citigroup Downgraded its Buy to Neutral on May 22, 2024, whereas the target price for the stock was revised from $16 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’24 when Boughton Soleil bought 2,339 shares for $18.50 per share.
Okupe Oluyemi sold 12,651 shares of HIMS for $212,356 on Sep 20 ’24. The Chief Financial Officer now owns 211,000 shares after completing the transaction at $16.79 per share. On Sep 20 ’24, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 45,767 shares for $16.33 each. As a result, the insider received 747,434 and left with 67,015 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 4179574272 and an Enterprise Value of 3897846528. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 253.34, and their Forward P/E ratio for the next fiscal year is 25.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.84 while its Price-to-Book (P/B) ratio in mrq is 11.35. Its current Enterprise Value per Revenue stands at 3.653 whereas that against EBITDA is 145.502.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is 11.59%, while the 200-Day Moving Average is calculated to be 26.47%.
Shares Statistics:
It appears that HIMS traded 8.07M shares on average per day over the past three months and 6574480 shares per day over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 173.82M. Insiders hold about 19.70% of the company’s shares, while institutions hold 56.86% stake in the company. Shares short for HIMS as of 1726185600 were 26537491 with a Short Ratio of 3.29, compared to 1723680000 on 23042592. Therefore, it implies a Short% of Shares Outstanding of 26537491 and a Short% of Float of 13.99.
